|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 8280 WILLOW OAKS CORPORATE DRIVE |
Address2 | SUITE 500 |
City | FAIRFAX |
State | VA |
Zip Code | 22031 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 57737-12
|
||||||||
|
6. House ID# 352510000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Laura Thevenot, Chief Executive Officer |
Date | 10/17/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
SConRes70 / HConRes321 (2009 Budget Resolution); S 3230 (Labor-HHS appropriations) regarding the appropriations allocation for National Institutes of Health (NIH) and the National Cancer Institute (NCI); allocation for implementation of the "Nurse Reinvestment Act" and other nursing workforce development programs at the Health Resources and Service Administration (HRSA); funding for the Department of Energy's nuclear medicine research medical applications program.
HR 2642 (Supplemental Appropriations Act of 2008) reguarding increased funding for NIH and NCI.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Adler |
|
|
|
Emily |
Wilson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 3014 (Health Equity and Accountability Act of 2007) to expand culturally and linguistically appropriate health care service and to address racial and ethnic disparities.
Legislation to reform health care through a combination of public and private approaches to cover medically necessary services.
HR 6791 (National Cancer Fund Act of 2008) to increase federal taxes on tobacco products and dedicate these revenues to increased cancer research funding.
Anticipated legislation from Senators Kennedy and Hutchinson to address unique cancer needs of patients and to renew and revive programs to cure cancer.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Adler |
|
|
|
Emily |
Wilson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S 2785 (Save Medicare Act of 2008) to stabilize Medicare physician payments.
HR 6331 (Medicare Improvements for Patients and Providers Act of 2008) to stabilize Medicare physicians payments.
HR 2749/ S 1519 (Voluntary Medicare Quality Reporting Act of 2007) to evaluate the Physician Quality Reporting Initiative.
HR 583/ S 1042 (Consistency Accuracy Responsibility (CARE) in Medical Imagining and Radiation Therapy Act of 2007) to establish standards for personnel who perform, plan, evaluate, or verify patient dose for medical imagining studies and radiation therapy standards.
HR 1078 (Comprehensive Cancer Care Improvement Act of 2007) to expand cancer care planning, comprehension system management and to authorize demonstrations for hospice and palliative care for cancer patients.
S 2029 (Physicians Payments Sunshine Act of 2007) to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Adler |
|
|
|
Emily |
Wilson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
To protect access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radiosurgery.
HR 5624 (Radiological Materials Security Act) to secure domestic sources of radiological materials that could be used to make a radiological dispersion device against access by terrorists.
HR 6816 (Nuclear Facility and Materials Security Act of 2008) regarding provisions related to the use of cesium chloride in medical research and cancer treatments.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Emily |
Wilson |
|
|
|
Richard |
Martin |
Esq. |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |